CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · IEX Real-Time Price · USD
4.960
-0.020 (-0.40%)
Jul 2, 2024, 3:48 PM EDT - Market closed
CollPlant Biotechnologies Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for CLGN stock has a target of 11, which predicts an increase of 121.77% from the current stock price of 4.96.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 30, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for CLGN is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +121.77% | May 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +121.77% | Apr 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +121.77% | Nov 30, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +121.77% | Aug 25, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $26 → $11 | Strong Buy | Maintains | $26 → $11 | +121.77% | Mar 30, 2023 |
Financial Forecast
Revenue This Year
2.86M
from 10.96M
Decreased by -73.94%
Revenue Next Year
14.79M
from 2.86M
Increased by 417.86%
EPS This Year
-1.49
from -0.62
EPS Next Year
-0.56
from -1.49
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 2.9M | 15.2M | 22.8M |
| Avg | 2.9M | 14.8M | 22.1M |
| Low | 2.7M | 14.2M | 21.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -73.2% | 433.1% | 53.9% |
| Avg | -73.9% | 417.9% | 49.6% |
| Low | -75.0% | 397.5% | 43.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.53 | -0.58 | -0.04 |
| Avg | -1.49 | -0.56 | -0.04 |
| Low | -1.43 | -0.54 | -0.04 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.